Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein

27 Jul 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to Genetic factors in colorectal cancer
Share to Genomics and Chromatin Dynamics

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 27464795
DOI: 10.1007/s10549-016-3915-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response proteinPMID 27464795Read ↗

High RAD51 Gene Expression is Associated with Aggressive Biology and with Poor Survival in Breast CancerSemantic proximity Read ↗

Comprehensive Analysis of the Expression and Prognosis for RAD51 Family in Human Breast CancerSemantic proximity Read ↗

RAD51 as a potential surrogate marker for DNA repair capacity in solid malignanciesSemantic proximity Read ↗

Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.Semantic proximity Read ↗

Identification of Rad51 alteration in patients with bilateral breast cancerSemantic proximity Read ↗

High RAD51 mRNA expression characterize estrogen receptor‐positive/progesteron receptor‐negative breast cancer and is associated with patient's outcomeSemantic proximity Read ↗

RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review)Semantic proximity Read ↗

CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cellsSemantic proximity Read ↗

RAD51 as a potential biomarker and therapeutic target for pancreatic cancerSemantic proximity Read ↗

Regulation and pharmacological targeting of RAD51 in cancerSemantic proximity Read ↗

RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.Semantic proximity Read ↗

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.